Showing 34,817 results

Vaginal rings & topical PrEP

Advocates Applaud Launch of MTN-017, World’s First Phase II Rectal Microbicide Study

Editor's pick
IRMA
2 October 2014
Human rights

Morocco's quiet revolution over AIDS and human rights

Editor's pick
Aidspan
2 October 2014
Treatment for women

Is A Study Of HIV Treatment For Mothers In Africa Unethical?

Editor's pick
Health Affairs (blog)
2 October 2014
The search for a cure

Research Toward a Cure Trials

Editor's pick
Treatment Action Group
2 October 2014
Hepatitis B

People with hepatitis B who have cirrhosis should be prioritised for liver cancer screening

News
2 October 2014
PrEP

Would an HIV-preventing drug change your world?

Editor's pick
BBC World Have Your Say (audio)
1 October 2014
Starting treatment

Why I Refused, Then Later Embraced, HIV Treatment

Editor's pick
TheBody.com
1 October 2014
Religion & faith

The Impact of Faith-Based Organisations on Public Health and Social Capital

Editor's pick
Faith Action
1 October 2014
Cancer

Population-based evidence for the preventative efficacy of quadrivalent HPV in Australia

Editor's pick
BMJ Group blogs
1 October 2014
Activism & civil society

Treatment Action Campaign faces closure

Editor's pick
Health-e
1 October 2014
Pharmaceutical industry

Europe: Pharma industry denies it lobbied for medicines to move to DG Enterprise

Editor's pick
EurActiv
1 October 2014
HIV & criminal law

While Rosemary Namubiru awaits appeal hearing, Uganda’s HIV response, healthworkers living in Uganda with HIV face questionable future

Editor's pick
Science Speaks
1 October 2014
Bone & joint problems

The puzzle of thin bones in young MSM

Editor's pick
CATIE
1 October 2014
Hepatitis C transmission & prevention

Investigating an outbreak of hepatitis C virus among MSM without HIV

Editor's pick
CATIE
1 October 2014
Exposure to HIV through medical procedures

Lifting U.S. Gay Blood Ban Could Increase Supply by 2% to 4%

Editor's pick
Poz magazine news
1 October 2014
The search for a cure

Monkey Study Suggests Radiation Didn’t Cure ‘Berlin Patient’ of HIV

Editor's pick
AIDSMeds
1 October 2014
Adherence

Exclusive: India set to run out of critical free drug for HIV/AIDS program

Editor's pick
Reuters
1 October 2014
Pharmaceutical industry

J&J makes a splash in hep C with a $1.75B deal for Alios

Editor's pick
Fierce Biotech
1 October 2014
Hepatitis C treatment

France uses tax to put pressure on hepatitis C drug prices

Editor's pick
Reuters
1 October 2014
PrEP

NYC promotes acceptance of controversial HIV drug

Editor's pick
Newsday
1 October 2014
TB diagnosis

UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition

Editor's pick
EATG
1 October 2014
New & experimental HIV treatments

CHMP Announces Positive Opinion for REZOLSTA™, a New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir and Cobicistat

Editor's pick
Janssen press release
1 October 2014
PrEP programmes & uptake

PrEP will need high adherence, high effectiveness and high coverage in specific populations to be affordable in the US, New York study finds

News
1 October 2014
Government, leadership & policy

Selling the End of AIDS

Editor's pick
Poz
1 October 2014